Quidel's QuickVue
This article was originally published in The Gray Sheet
Executive Summary
Dipstick Strep A test joins Wyntek's OSOM Ultra as only CLIA-waived tests for the diagnosis of Group A Streptococcal infection. San Diego-based Quidel also markets the QuickVue CLIA-waived rapid influenza test. Separately, Quidel reported second quarter revenues of $15.5 mil., off 6.6%. A net loss of $866,000 compares to a loss of $61,000 for the comparable quarter last year